Apollo Hospitals has reached a significant milestone by introducing the ZAP-X Gyroscopic Radiosurgery Platform, marking the first implementation of this innovative technology in South Asia. ZAP-X heralds a new era in brain tumor treatment, providing patients with a non-invasive, pain-free option with brief treatment sessions lasting just 30 minutes. This technology enhances precision while minimizing radiation exposure, setting new benchmarks for treatment effectiveness and patient comfort.

Unlike traditional methods, ZAP-X utilizes a self-shielded, gyroscopic linear accelerator design to deliver radiosurgical beams from multiple angles, ensuring precise targeting of tumors or specific areas. In contrast to lengthy brain surgeries lasting 3-4 hours, ZAP-X offers a single-session treatment lasting no more than 30 minutes, enabling outpatient procedures and facilitating quicker recovery.

ZAP-X has demonstrated impressive success rates, achieving over 95% control rate in 10 years and an exceptional 99.4% control rate in 5 years for small, defined tumors. This success underscores its efficacy in providing relief with minimal side effects. The technology enables neurologists and neurosurgeons to treat various conditions more accurately and with reduced risks.

The Apollo Institute of Neurosciences is renowned for its leadership in neurological care, having performed over 180,000 successful neurosurgeries and supported by a team of over 300 specialists who annually treat 25,000 patients. The introduction of the ZAP-X platform reaffirms Apollo's dedication to driving innovations that improve patient care and outcomes.

Additionally, Apollo Hospitals has revolutionized stroke protocols through the use of smart technology, enabling faster and more precise treatment interventions. By leveraging cutting-edge technologies, Apollo continues to lead in medical innovation, striving to enhance healthcare delivery and positively impact patient lives.

Source: prnewswire.com

Report Abuse